MA33935B1 - Animal non humain transgénique et utilisations de celui-ci - Google Patents

Animal non humain transgénique et utilisations de celui-ci

Info

Publication number
MA33935B1
MA33935B1 MA35079A MA35079A MA33935B1 MA 33935 B1 MA33935 B1 MA 33935B1 MA 35079 A MA35079 A MA 35079A MA 35079 A MA35079 A MA 35079A MA 33935 B1 MA33935 B1 MA 33935B1
Authority
MA
Morocco
Prior art keywords
transgenic
methods
genetically modified
human animal
constructs
Prior art date
Application number
MA35079A
Other languages
Arabic (ar)
English (en)
Inventor
Holly Dressler
Kyriakos D Economides
Zhen Pang
Harry Gregory Polites
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of MA33935B1 publication Critical patent/MA33935B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0069—Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A01K2217/052—Animals comprising random inserted nucleic acids (transgenic) inducing gain of function
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/20—Animal model comprising regulated expression system
    • A01K2217/203—Animal model comprising inducible/conditional expression system, e.g. hormones, tet
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0393—Animal model comprising a reporter system for screening tests
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/106—Plasmid DNA for vertebrates
    • C12N2800/107—Plasmid DNA for vertebrates for mammalian
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/15—Vector systems having a special element relevant for transcription chimeric enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/40—Vector systems having a special element relevant for transcription being an insulator
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/46—Vector systems having a special element relevant for transcription elements influencing chromatin structure, e.g. scaffold/matrix attachment region, methylation free island
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/50—Vector systems having a special element relevant for transcription regulating RNA stability, not being an intron, e.g. poly A signal
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/60—Vector systems having a special element relevant for transcription from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Environmental Sciences (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • General Physics & Mathematics (AREA)
  • Animal Husbandry (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)

Abstract

La présente invention concerne de manière générale des constructions transgéniques, des animaux non humains transgéniques qui comprennent les constructions transgéniques, des procédés de fabrication et des procédés d'utilisation des animaux non humains transgéniques qui comprennent les constructions transgéniques. Un mode de réalisation de l'invention concerne des procédés de test de l'activation de ligand GPCR de manière non invasive dans des animaux entiers, des coupes de tissus, ou des cellules natives en utilisant un modèle transgénique contenant un système rapporteur transgénique bioluminescent qui réagit à la modulation de la voie après la liaison au ligand des récepteurs GPCR.
MA35079A 2009-12-21 2010-12-17 Animal non humain transgénique et utilisations de celui-ci MA33935B1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US28848009P 2009-12-21 2009-12-21
US29897310P 2010-01-28 2010-01-28
US31891910P 2010-03-30 2010-03-30
FR1057663 2010-09-23
PCT/US2010/060909 WO2011084659A1 (fr) 2009-12-21 2010-12-17 Animal non humain transgénique et utilisations associées

Publications (1)

Publication Number Publication Date
MA33935B1 true MA33935B1 (fr) 2013-01-02

Family

ID=44305727

Family Applications (1)

Application Number Title Priority Date Filing Date
MA35079A MA33935B1 (fr) 2009-12-21 2010-12-17 Animal non humain transgénique et utilisations de celui-ci

Country Status (17)

Country Link
US (1) US8981179B2 (fr)
EP (1) EP2516634A1 (fr)
JP (1) JP5944833B2 (fr)
KR (1) KR20120108013A (fr)
CN (1) CN102892881B (fr)
AR (1) AR079547A1 (fr)
AU (1) AU2010339858B2 (fr)
CA (1) CA2784429A1 (fr)
CO (1) CO6541640A2 (fr)
MA (1) MA33935B1 (fr)
MX (1) MX2012006884A (fr)
NZ (1) NZ600711A (fr)
PH (1) PH12012501163A1 (fr)
RU (1) RU2579701C2 (fr)
SG (1) SG181593A1 (fr)
TW (1) TW201134943A (fr)
WO (1) WO2011084659A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU230964B1 (hu) 2014-11-28 2019-06-28 Magyar Tudományos Akadémia Kísérleti Orvostudományi Kutatóintézet Pajzsmirigyhormon-hatás mérésére szolgáló transzgenikus indikátor egér és rekombináns DNS-konstrukció
US20200400567A1 (en) * 2017-09-27 2020-12-24 Peking University Fusion polypeptide
CN113501881B (zh) * 2017-09-27 2023-07-28 北京大学 融合蛋白
CN112514822A (zh) * 2020-12-16 2021-03-19 真木农业设备（安徽）有限公司 一种多层养鸡笼人工鸡蛋收集装置

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0876483A1 (fr) * 1996-01-26 1998-11-11 HSC Research and Development Limited Partnership Acides nucleiques et proteines lies a la maladie d'alzheimer et leurs utilisations
EP1066112B1 (fr) 1998-03-27 2002-12-11 Aventis Pharma Deutschland GmbH Plaque de microtitrage miniaturisee pour criblage a debit eleve
WO2003087311A2 (fr) * 2002-04-05 2003-10-23 Emory University Elements regulateurs de prlz dans le traitement de maladies et decouverte d'agents therapeutiques
WO2004042363A2 (fr) * 2002-11-04 2004-05-21 Dana-Farber Cancer Institute, Inc. Imagerie in vivo de proteines bioluminescentes regulees par e2f
EP1594955B1 (fr) * 2003-02-14 2012-04-11 Biogen Idec MA Inc. Cassette et vecteur d'expression pour l'expression transitoire ou stable de molecule exogenes
US20050283854A1 (en) * 2003-05-23 2005-12-22 Anton Krumm Recombinant vectors for use in position-independent transgene expression within chromatin
CN100387722C (zh) * 2004-02-18 2008-05-14 中国人民解放军军事医学科学院生物工程研究所 一种中枢神经系统特异性表达Cre重组酶的转基因小鼠的制备方法
WO2010118360A1 (fr) * 2009-04-09 2010-10-14 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Production de protéines au moyen de vecteurs à base de transposon

Also Published As

Publication number Publication date
TW201134943A (en) 2011-10-16
JP5944833B2 (ja) 2016-07-05
AR079547A1 (es) 2012-02-01
RU2579701C2 (ru) 2016-04-10
AU2010339858B2 (en) 2016-01-28
MX2012006884A (es) 2012-07-04
CO6541640A2 (es) 2012-10-16
CN102892881A (zh) 2013-01-23
NZ600711A (en) 2014-06-27
RU2012131399A (ru) 2014-01-27
US20120255041A1 (en) 2012-10-04
JP2013514808A (ja) 2013-05-02
PH12012501163A1 (en) 2019-07-10
WO2011084659A1 (fr) 2011-07-14
KR20120108013A (ko) 2012-10-04
EP2516634A1 (fr) 2012-10-31
AU2010339858A1 (en) 2012-07-12
CN102892881B (zh) 2015-01-07
US8981179B2 (en) 2015-03-17
SG181593A1 (en) 2012-07-30
CA2784429A1 (fr) 2011-07-14

Similar Documents

Publication Publication Date Title
Stevens et al. Predicting diet, trophic level and palaeoecology from bone stable isotope analysis: a comparative study of five red deer populations
UA111936C2 (uk) ТРАНСГЕННА РОСЛИНА, ЯКА МІСТИТЬ ДНК, ЩО КОДУЄ ІНСЕКТИЦИДНИЙ БІЛОК Vip3Ab, І ДНК, ЩО КОДУЄ ІНСЕКТИЦИДНИЙ БІЛОК Cry1Ca, ДЛЯ КЕРУВАННЯ РЕЗИСТЕНТНІСТЮ КОМАХ
AR062614A1 (es) Expresion de inmunologlobulina humana o humanizada en animales transgenicos no humanos
BRPI0916624A2 (pt) anticorpos monoclonais seletivos anti-hepcidina-25, seus usos, bem como método e kit para quantificar a quantidade de proteína hepcidina-25 em uma amostra de tecido ou fluido biológico
RU2018136614A (ru) Отличные от человека животные с гуманизированным геном сигнального регуляторного белка
GB2462764A (en) Ex vivo methods for validating substance testing with human organs and or tissues
EA200800448A1 (ru) Нуклеотидные последовательности, кодирующие инсектицидные белки
MX344313B (es) Uso combinado de las proteinas cry1ca y cry1ab para el control de la resistencia a los insectos.
WO2006113352A3 (fr) Biodetecteur implantable
MX2019004871A (es) Animales no humanos humanizados con loci de cadena pesada de inmunoglobulina restringidos.
PT2203176E (pt) Supressão de tumor utilizando perfusato placentário humano e células assassinas naturais intermédias derivadas de placenta humanas
EP2279523A4 (fr) Cellules de mémoire, constructions de cellules de mémoire et procédés de programmation de cellules de mémoire
WO2009088876A3 (fr) Animaux non humains transgéniques exprimant des facteurs de coagulation du sang humain, et leurs utilisations
DE602005024833D1 (de) Diagnostik und screening-methode und kit in verbindung mit proteolytischer aktivität
SV2010003533A (es) Anticuerpos anti-amiloide, composiciones, metodos y usos
WO2009034158A3 (fr) Souris transgéniques
WO2006001021A3 (fr) Systeme de criblage fonctionnant sur la base d'elements aviaires chimeres contenant des greffes mammiferes
EP2084534A4 (fr) Procédés d'identification, d'isolement et d'utilisation de cellules progénitrices endocrines provenant de pancréas humain adulte
DE602005004522D1 (de) Kauspielzeug für tiere
ATE510849T1 (de) Transgene nichtmenschliche leuchttiere, abkömmling, zellderivate und verwendung
WO2010025736A3 (fr) Système détecteur de récepteurs nucléaires dans un animal transgénique
WO2008153543A3 (fr) Modèle murin fluorescent
EP2034018A4 (fr) Animal genetiquement modifie et son utilisation
WO2006099160A3 (fr) Systemes de transfert d'energie de resonance de bioluminescence (bret) et leurs procedes d'utilisation
EP1874114A4 (fr) Animal modifié dépourvu du gène pyy fonctionnel, anticorps monoclonaux fixant les isoformes pyy et leurs utilisations